ArticleBreast cancer (Dove Medical Press)2025

Bystin is a Prognosis and Immune Biomarker: From Pan-Cancer Analysis to Validation in Breast Cancer.

Xiyidan Aimaiti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.